MJ Coffey, SE Wilcoxen and M Peters-Golden
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.

The capacity for 5-lipoxygenase (5-LO) metabolism of endogenous arachidonic acid (AA) is greater in alveolar macrophages (AM) than in their circulating precursors, peripheral blood monocytes (PBM); however, the ability of PBM to metabolize exogenous AA to 5-LO products is comparable to that of AM. In the present study, we examined the enzymatic mechanisms by which 5-LO metabolism of AA is altered during differentiation of PBM in the lung. Resting human AM exhibited greater steady-state levels of 5-LO (7-fold) and LTA4 hydrolase (2-fold) proteins than autologous PBM; moreover, they differed from PBM in that they contained a significant amount of 5-LO associated with the particulate fraction. Importantly, AM contained 40-fold more 5- lipoxygenase activating protein (FLAP) than did PBM, which correlated well with the relative abilities of intact AM and PBM to metabolize endogenous AA to leukotrienes. The FLAP inhibitor MK-886 was unable to block leukotriene synthesis from exogenous AA in the two cell types, despite its ability to completely inhibit 5-LO metabolism of endogenous AA. These observations indicate that, although FLAP is essential for the synthesis of leukotrienes from endogenous AA, perhaps by presenting AA to 5-LO, it is not required for 5-LO metabolism of exogenous AA. The differing roles of FLAP in 5-LO metabolism of endogenous versus exogenous AA are consistent with the conclusion that it is the markedly greater expression of FLAP, rather than of 5-LO, that is primarily responsible for the increased leukotriene synthesis from endogenous AA that accompanies PBM differentiation into AM.

This article has been cited by other articles:

				F. Herb, T. Thye, S. Niemann, E. N.L. Browne, M. A. Chinbuah, J. Gyapong, I. Osei, E. Owusu-Dabo, O. Werz, S. Rusch-Gerdes, et al. ALOX5 variants associated with susceptibility to human pulmonary tuberculosis Hum. Mol. Genet., April 1, 2008; 17(7): 1052 - 1060. [Abstract] [Full Text] [PDF]

				M. J. Coffey, C. H. Serezani, S. M. Phare, N. Flamand, and M. Peters-Golden NADPH oxidase deficiency results in reduced alveolar macrophage 5-lipoxygenase expression and decreased leukotriene synthesis J. Leukoc. Biol., December 1, 2007; 82(6): 1585 - 1591. [Abstract] [Full Text] [PDF]

				H. Harizi, M. Juzan, J.-F. Moreau, and N. Gualde Prostaglandins Inhibit 5-Lipoxygenase-Activating Protein Expression and Leukotriene B4 Production from Dendritic Cells Via an IL-10-Dependent Mechanism J. Immunol., January 1, 2003; 170(1): 139 - 146. [Abstract] [Full Text] [PDF]

				M. J. Coffey, S. M. Phare, and M. Peters-Golden Peroxynitrite-Induced Nitrotyrosination of Proteins Is Blocked by Direct 5-Lipoxygenase Inhibitor Zileuton J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 198 - 203. [Abstract] [Full Text] [PDF]

				R. Malaviya, C.-L. Chen, C. Navara, R. Malaviya, X.-P. Liu, M. Keenan, B. Waurzyniak, and F. M. Uckun Treatment of Allergic Asthma by Targeting Janus Kinase 3-Dependent Leukotriene Synthesis in Mast Cells with 4-(3',5'-Dibromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97) J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 912 - 926. [Abstract] [Full Text]

				M. J. Coffey, S. M. Phare, and M. Peters-Golden Prolonged Exposure to Lipopolysaccharide Inhibits Macrophage 5-Lipoxygenase Metabolism Via Induction of Nitric Oxide Synthesis J. Immunol., October 1, 2000; 165(7): 3592 - 3598. [Abstract] [Full Text] [PDF]

				A. M. Healy, M. Peters-Golden, J. P. Yao, and T. G. Brock Identification of a Bipartite Nuclear Localization Sequence Necessary for Nuclear Import of 5-Lipoxygenase J. Biol. Chem., October 15, 1999; 274(42): 29812 - 29818. [Abstract] [Full Text] [PDF]

				A. S. Cowburn, S. T. Holgate, and A. P. Sampson IL-5 Increases Expression of 5-Lipoxygenase-Activating Protein and Translocates 5-Lipoxygenase to the Nucleus in Human Blood Eosinophils J. Immunol., July 1, 1999; 163(1): 456 - 465. [Abstract] [Full Text] [PDF]

				J. M. Drazen, E. Israel, and P. M. O'Byrne Treatment of Asthma with Drugs Modifying the Leukotriene Pathway N. Engl. J. Med., January 21, 1999; 340(3): 197 - 206. [Full Text] [PDF]

				M. J. Tino and J. R. Wright Surfactant proteins A and D specifically stimulate directed actin-based responses in alveolar macrophages Am J Physiol Lung Cell Mol Physiol, January 1, 1999; 276(1): L164 - L174. [Abstract] [Full Text] [PDF]

				P. Mancuso, T. J. Standiford, T. Marshall, and M. Peters-Golden 5-Lipoxygenase Reaction Products Modulate Alveolar Macrophage Phagocytosis of Klebsiella pneumoniae Infect. Immun., November 1, 1998; 66(11): 5140 - 5146. [Abstract] [Full Text] [PDF]

				R. B. Covin, T. G. Brock, M. B. Bailie, and M. Peters-Golden Altered expression and localization of 5-lipoxygenase accompany macrophage differentiation in the lung Am J Physiol Lung Cell Mol Physiol, August 1, 1998; 275(2): L303 - L310. [Abstract] [Full Text] [PDF]

				T. G. Brock, R. W. McNish, M. B. Bailie, and M. Peters-Golden Rapid Import of Cytosolic 5-Lipoxygenase into the Nucleus of Neutrophils after in Vivo Recruitment and in Vitro Adherence J. Biol. Chem., March 28, 1997; 272(13): 8276 - 8280. [Abstract] [Full Text] [PDF]

				L. WRIGHT, R. M. TUDER, J. WANG, C. D. COOL, R. A. LEPLEY, and N. F. VOELKEL 5-Lipoxygenase and 5-Lipoxygenase Activating Protein (FLAP) Immunoreactivity in Lungs from Patients with Primary Pulmonary Hypertension Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 219 - 229. [Abstract] [Full Text]

				T. G. Brock, R. W. McNish, and M. Peters-Golden Translocation and Leukotriene Synthetic Capacity of Nuclear 5-Lipoxygenase in Rat Basophilic Leukemia Cells and Alveolar Macrophages J. Biol. Chem., September 15, 1995; 270(37): 21652 - 21658. [Abstract] [Full Text] [PDF]